MedTrace Logo

Study Using the CervicalStim Device Following Cervical Fusion

NCT03177473 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 211

Last updated 2022-09-16

No results posted yet for this study

Summary

This study examines the effect of adjunctive use of the CervicalStim bone growth stimulator on cervical fusion rate in high risk subjects who have undergone cervical fusion surgery. All participants will wear the bone growth stimulator every day for 4 hours/day for 6 months.

Conditions

  • Vertebral Cervical Fusion Syndrome
  • Degenerative Disc Disease

Interventions

DEVICE

CervicalStim bone growth stimulator

Orthofix CervicalStim bone growth stimulator

Sponsors & Collaborators

  • Orthofix Inc.

    lead INDUSTRY

Principal Investigators

  • James T Ryaby, PhD · Orthofix Inc.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-28
Primary Completion
2021-08-03
Completion
2021-08-03
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03177473 on ClinicalTrials.gov